Characteristics and Outcome of Patients with COVID-19 Complicated by Takotsubo Cardiomyopathy: Case Series with Literature Review

Overview

Journal Open Heart

Publisher BMJ Publishing Group

Specialty Cardiology & Vascular Diseases

Date 2020 Oct 6

PMID 33020258

Citations 25

Authors

Shruti Hegde

Rizwan Khan

Magdi Zordok

Michael Maysky

Affiliations

Soon will be listed here.

Abstract

Background: Cardiac involvement with COVID-19 is increasingly being recognised. Clinical characteristics and outcomes of patients with COVID-19 complicated by secondary Takotsubo cardiomyopathy (TC) is poorly understood.

Methods: This retrospective case series was conducted between March and April 2020 at four hospitals of Steward Health Care Network of Massachusetts, USA. Seven patients out of 169 who had echocardiogram were identified to have features of TC. Demographic, clinical, laboratory, management and outcome were gathered from their electronic medical records. We also reviewed all the published cases of COVID-19 and TC in the literature to recognise their common clinical characteristics, risk factors and outcomes.

Results: In our series of seven patients, three typical, two inverted, one biventricular and one global TC were recognised. Three were females and four were males. The mean age was 71±11 years. In-hospital death was observed in 57% of patients. Patients who belonged to the high-risk group and had high-risk echocardiographic features in our series had a 100% mortality rate.

Conclusions: COVID-19 complicated by TC has a high mortality rate. Early identification of patients with COVID-19 who are at higher risk for developing secondary TC is important for the prevention of complications, and thus improved outcomes.

Citing Articles

Association between echocardiographic features, troponin levels, and survival time in hospitalized COVID-19 patients with cardiovascular events.

Furmanek S, Salunkhe V, Pahwa S, Samanapally H, Nathala P, Xu Q J Anesth Transl Med. 2024; 3(2):36-44.

PMID: 38993392 PMC: 11238549. DOI: 10.1016/j.jatmed.2024.05.001.

Role of POCUS in the Management of New-onset Tachyarrhythmia in the Setting of SARS-CoV-2: A Case Report.

Sivasubramanian B, Ravikumar D, Vyas B, Panchal V, Puli S, Kiernan G J Community Hosp Intern Med Perspect. 2024; 13(6):50-53.

PMID: 38596561 PMC: 11000831. DOI: 10.55729/2000-9666.1261.

"When," "Where," and "How" of SARS-CoV-2 Infection Affects the Human Cardiovascular System: A Narrative Review.

Kounis N, Gogos C, de Gregorio C, Hung M, Kounis S, Tsounis E Balkan Med J. 2024; 41(1):7-22.

PMID: 38173173 PMC: 10767774. DOI: 10.4274/balkanmedj.galenos.2023.2023-10-25.

Takotsubo syndrome and COVID-19: A systematic review.

Ghasemi H, Kazemian S, Nejadghaderi S, Shafie M Health Sci Rep. 2022; 6(1):e972.

PMID: 36479387 PMC: 9718950. DOI: 10.1002/hsr2.972.

Acute Coronary Syndrome in Patients with SARS-CoV-2 Infection: Pathophysiology and Translational Perspectives.

Cancro F, Bellino M, Esposito L, Romei S, Centore M, DElia D Transl Med UniSa. 2022; 24(2):1-11.

PMID: 36447945 PMC: 9673986. DOI: 10.37825/2239-9754.1034.

References

Sherif K, Sehli S, Jenkins L . Takotsubo cardiomyopathy after administration of norepinephrine. Proc (Bayl Univ Med Cent). 2016; 29(2):166-7. PMC: 4790558. DOI: 10.1080/08998280.2016.11929402. View

Ghadri J, Wittstein I, Prasad A, Sharkey S, Dote K, Akashi Y . International Expert Consensus Document on Takotsubo Syndrome (Part I): Clinical Characteristics, Diagnostic Criteria, and Pathophysiology. Eur Heart J. 2018; 39(22):2032-2046. PMC: 5991216. DOI: 10.1093/eurheartj/ehy076. View

Elesber A, Prasad A, Bybee K, Valeti U, Motiei A, Lerman A . Transient cardiac apical ballooning syndrome: prevalence and clinical implications of right ventricular involvement. J Am Coll Cardiol. 2006; 47(5):1082-3. DOI: 10.1016/j.jacc.2005.12.004. View

Hessel 2nd E . Takotsubo cardiomyopathy and its relevance to anesthesiology: a narrative review. Can J Anaesth. 2016; 63(9):1059-74. DOI: 10.1007/s12630-016-0680-4. View

Elikowski W, Malek-Elikowska M, Lisiecka M, Trypuc Z, Mozer-Lisewska I . Takotsubo cardiomyopathy triggered by influenza B. Pol Merkur Lekarski. 2018; 45(266):67-70. View

Lyon A, Bossone E, Schneider B, Sechtem U, Citro R, Underwood S . Current state of knowledge on Takotsubo syndrome: a Position Statement from the Taskforce on Takotsubo Syndrome of the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail. 2015; 18(1):8-27. DOI: 10.1002/ejhf.424. View

Medina DE Chazal H, Del Buono M, Keyser-Marcus L, Ma L, Moeller F, Berrocal D . Stress Cardiomyopathy Diagnosis and Treatment: JACC State-of-the-Art Review. J Am Coll Cardiol. 2018; 72(16):1955-1971. PMC: 7058348. DOI: 10.1016/j.jacc.2018.07.072. View

Templin C, Ghadri J, Diekmann J, Napp L, Bataiosu D, Jaguszewski M . Clinical Features and Outcomes of Takotsubo (Stress) Cardiomyopathy. N Engl J Med. 2015; 373(10):929-38. DOI: 10.1056/NEJMoa1406761. View

Golfeyz S, Kobayashi T, Aoi S, Harrington M . Possible association of influenza A infection and reverse takotsubo syndrome. BMJ Case Rep. 2018; 11(1). PMC: 6301597. DOI: 10.1136/bcr-2018-226289. View

10.

Shi S, Qin M, Shen B, Cai Y, Liu T, Yang F . Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan, China. JAMA Cardiol. 2020; 5(7):802-810. PMC: 7097841. DOI: 10.1001/jamacardio.2020.0950. View

11.

Paur H, Wright P, Sikkel M, Tranter M, Mansfield C, OGara P . High levels of circulating epinephrine trigger apical cardiodepression in a β2-adrenergic receptor/Gi-dependent manner: a new model of Takotsubo cardiomyopathy. Circulation. 2012; 126(6):697-706. PMC: 4890655. DOI: 10.1161/CIRCULATIONAHA.112.111591. View

12.

Citro R, Rigo F, DAndrea A, Ciampi Q, Parodi G, Provenza G . Echocardiographic correlates of acute heart failure, cardiogenic shock, and in-hospital mortality in tako-tsubo cardiomyopathy. JACC Cardiovasc Imaging. 2014; 7(2):119-29. DOI: 10.1016/j.jcmg.2013.09.020. View

13.

Roca E, Lombardi C, Campana M, Vivaldi O, Bigni B, Bertozzi B . Takotsubo Syndrome Associated with COVID-19. Eur J Case Rep Intern Med. 2020; 7(5):001665. PMC: 7213829. DOI: 10.12890/2020_001665. View

14.

Singh K, Carson K, Shah R, Sawhney G, Singh B, Parsaik A . Meta-analysis of clinical correlates of acute mortality in takotsubo cardiomyopathy. Am J Cardiol. 2014; 113(8):1420-8. DOI: 10.1016/j.amjcard.2014.01.419. View

15.

Khera R, Light-McGroary K, Zahr F, Horwitz P, Girotra S . Trends in hospitalization for takotsubo cardiomyopathy in the United States. Am Heart J. 2016; 172:53-63. PMC: 4748175. DOI: 10.1016/j.ahj.2015.10.022. View

16.

Minhas A, Scheel P, Garibaldi B, Liu G, Horton M, Jennings M . Takotsubo Syndrome in the Setting of COVID-19. JACC Case Rep. 2020; 2(9):1321-1325. PMC: 7194596. DOI: 10.1016/j.jaccas.2020.04.023. View

17.

Nguyen D, Nguyen T, De Bels D, Castro Rodriguez J . A case of Takotsubo cardiomyopathy with COVID 19. Eur Heart J Cardiovasc Imaging. 2020; 21(9):1052. PMC: 7239208. DOI: 10.1093/ehjci/jeaa152. View

18.

Stiermaier T, Eitel C, Desch S, Fuernau G, Schuler G, Thiele H . Incidence, determinants and prognostic relevance of cardiogenic shock in patients with Takotsubo cardiomyopathy. Eur Heart J Acute Cardiovasc Care. 2015; 5(6):489-496. DOI: 10.1177/2048872615612456. View

19.

Buzon J, Roignot O, Lemoine S, Perez P, Kimmoun A, Levy B . Takotsubo Cardiomyopathy Triggered by Influenza A Virus. Intern Med. 2015; 54(16):2017-9. DOI: 10.2169/internalmedicine.54.3606. View

20.

Meyer P, Degrauwe S, Van Delden C, Ghadri J, Templin C . Typical takotsubo syndrome triggered by SARS-CoV-2 infection. Eur Heart J. 2020; 41(19):1860. PMC: 7184501. DOI: 10.1093/eurheartj/ehaa306. View